Ardmore PD offers SafetyNet tracking for parents & caregivers

ARDMORE, Okla. (KFOR) – The Ardmore Police Department is now serving all of Carter County parents and caregivers of people with autism, dementia, Alzheimers, Down syndrome, or other cognitive disorders with SafetyNet Tracking Systems.
According to authorities, SafetyNet is a search and rescue system designed to find and rescue people at risk of wandering and becoming lost.
Quiet weather before more active storm pattern returns
Residents who participate can expect once enrolled to be outfitted with a bracelet (shown below) that can be worn on the wrist or ankle in any event they go missing.
Police say, if a loved one goes missing a receiver is used (shown above) to track the radio frequency signal that is emitted the last known location of your loved one.
SafetyNet uses RF (Radio Frequencies) instead of relying on GPS or cellular services and has reliability inside densely wooded areas and buildings.
For more information on enrollment click here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

13 hours ago

• Yahoo

The Sad Case of The World's Youngest-Ever Alzheimer's Diagnosis

In 2023, neurologists at a memory clinic in China diagnosed a 19-year-old with what they believed to be Alzheimer's disease – making him the youngest person ever to be diagnosed with the condition. The teen first began experiencing memory decline around age 17, with symptoms worsening over time. Brain scans revealed shrinkage in the hippocampus, a region involved in memory, while his cerebrospinal fluid showed biomarkers consistent with Alzheimer's – the most common form of dementia. Although usually associated with older age, early-onset cases of Alzheimer's (those occurring in individuals under age 65) represent up to 10 percent of all diagnoses. Almost all Alzheimer's patients under the age of 30 can have their disease explained by pathological gene mutations, classifying them as having familial Alzheimer's disease (FAD). The younger a person is when they receive a diagnosis, the more likely it is caused by an inherited faulty gene. However, researchers at Beijing's Capital Medical University were unable to find any of the usual mutations responsible for the early onset of memory loss, nor any suspect genes, after conducting a genome-wide search. Before this diagnosis in China, the youngest patient with Alzheimer's was 21 years old. They carried the PSEN1 gene mutation, which causes abnormal proteins to build up in the brain, forming clumps of toxic plaques, a common feature of Alzheimer's. Cases like this one pose something of a mystery. None of the 19-year-old's family had a history of Alzheimer's or dementia, making it hard to categorize it as FAD, yet the teenager had no other diseases, infections, or head trauma that could explain his sudden cognitive decline either. Two years before being referred to the memory clinic, the teenage patient began struggling to focus in class. Reading also became difficult and his short-term memory declined. Oftentimes, he couldn't remember events from the day before, and he was always misplacing his belongings. Ultimately, the cognitive decline became so bad, the young man was unable to finish high school, although he could still live independently. A year after being referred to the memory clinic, he showed losses in immediate recall, short-delay recall after three minutes, and long-delay recall after 30 minutes. The patient's full-scale memory score was 82 percent lower than that of peers his own age, while his immediate memory score was 87 percent lower. Long-term follow-up is needed to support the young man's diagnosis, but his medical team said at the time the patient was "altering our understanding of the typical age of onset of AD." "The patient had very early-onset AD with no clear pathogenic mutations," neurologist Jianping Jia and colleagues wrote in their study, "which suggests that its pathogenesis still needs to be explored." The case study, published in February 2023, just goes to show that Alzheimer's doesn't follow a single pathway, and is much more complex than we thought, emerging via numerous avenues with varying effects. In a statement to the South China Morning Post, the neurologists who described the patient's case argued that future studies should focus on early-onset cases to further improve our understanding of memory loss. "Exploring the mysteries of young people with Alzheimer's disease may become one of the most challenging scientific questions of the future," they said. The study was published in the Journal of Alzheimer's Disease. An earlier version of this article was published in February 2023. Compound That Turns People Yellow Could Protect Against Malaria Scientists May Have Finally Figured Out How Bats Avoid Cancer 'Off Switch' in The Brain to Stop Binge Drinking Discovered in Mice

Yahoo

a day ago

• Yahoo

Mary Beth Nienhaus Activity Center officially opens, providing social opportunities for adults 50+

APPLETON, Wis. (WFRV) – After all of the anticipation and excitement, the Mary Beth Nienhaus Activity Center has finally opened, with a celebration event on Friday afternoon. The activity center, formerly known as the , provides adults 50 years and older with plenty of opportunities to socialize, learn and thrive. Green Bay native Tony Shalhoub to host global food docuseries on CNN From wellness studios to high-tech classrooms and gaming areas, the facility features a plethora of ways for adults looking to keep up their activity level to do so. It also features the only indoor pickleball court for adults in Appleton. The center is still holding a fundraiser, looking to raise about $6.5 million, and it is 85% of the way there. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Yahoo

2 days ago

• Yahoo

How Is Hologic's Stock Performance Compared to Other Health Care Equipment Stocks?

With a market cap of $14.3 billion, Hologic, Inc. (HOLX) is a Massachusetts-based medical technology firm, primarily focused on women's health. The company develops, manufactures, and sells a comprehensive suite of solutions, including molecular diagnostics, medical imaging systems, and surgical devices Companies worth $10 billion or more are generally described as 'large-cap stocks,' and Hologic fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the medical instruments & supplies industry. The company benefits from robust innovation, supported by over 7,000 patents, which fuels its proprietary technologies and product differentiation. Its diagnostics segment, particularly in molecular testing, has shown strong growth, positioning Hologic well in the expanding global healthcare market. 2 Outstanding Stocks Under $50 to Buy and Hold Now Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here? A $1 Billion Reason to Buy MicroStrategy Stock Here Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. However, HOLX shares have retreated 24.5% from their 52-week high of $84.67 touched on Aug. 9, 2024. Meanwhile, HOLX stock has surged 3.2% over the past three months, surpassing the SPDR S&P Health Care Equipment ETF's (XHE) 4.8% plunge over the same time frame. HOLX stock has plummeted 11.3% on a YTD basis and 10.5% over the past 52 weeks, compared to XHE's 10.6% dip in 2025 and a 6.3% fall over the past year. The stock has remained consistently below its 200-day moving average since early December last year, but has climbed above its 50-day moving average since late May. On May 27, HOLX shares surged more than 14%, leading S&P 500 gainers, after reports emerged that TPG Inc. (TPG) and Blackstone Inc. (BX) made (and were turned down on) a non-binding ~$16 billion takeover bid, valuing the company at $70–$72 per share. The stock's rally reflected investor optimism and underscored the premium valuation placed on its leadership in women's health and diagnostic capabilities. In the competitive healthcare equipment industry, top rival, Align Technology, Inc.'s (ALGN) 13.7% drop on a YTD basis and 25.7% decline over the past year trails HOLX's losses in the same time frames. Among the 19 analysts covering the HOLX stock, the consensus rating is a 'Moderate Buy.' Its mean price target of $68.27 suggests a 6.7% upside potential from current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data